WHO

WHO

The World Health Organisation has launched a new Global Antimicrobial Surveillance System , a global effort to address drug resistance.

The GLASS will involve the development of tools and standards and improved collaboration around the world to track drug resistance, measure its health and economic impacts, and design targeted solutions.

WHO reported new surveillance data on Monday which reveals widespread resistance to some of the world’s most common infections, including E. coli and pneumonia.

The agency said Antimicrobials have been a driver of unprecedented medical and societal advances, but their overuse has resulted in antibiotic resistant bacteria.

Dr Marc Sprenger, Director of WHO’s Antimicrobial Resistance Secretariat, said at the launch of the agency’s GLASS that the report confirms the serious situation of antibiotic resistance worldwide,”